WO2006072685A3 - Procede de preparation d'une composition pharmaceutique solide a liberation prolongee et controlee par traitement sous hautes pressions - Google Patents

Procede de preparation d'une composition pharmaceutique solide a liberation prolongee et controlee par traitement sous hautes pressions Download PDF

Info

Publication number
WO2006072685A3
WO2006072685A3 PCT/FR2005/003203 FR2005003203W WO2006072685A3 WO 2006072685 A3 WO2006072685 A3 WO 2006072685A3 FR 2005003203 W FR2005003203 W FR 2005003203W WO 2006072685 A3 WO2006072685 A3 WO 2006072685A3
Authority
WO
WIPO (PCT)
Prior art keywords
prolonged
solid pharmaceutical
preparing
high pressure
controlled release
Prior art date
Application number
PCT/FR2005/003203
Other languages
English (en)
Other versions
WO2006072685A2 (fr
Inventor
Vassilios Kaltsatos
Patrick Forget
Eliane Boivin
Original Assignee
Ceva Sante Animale
Vassilios Kaltsatos
Patrick Forget
Eliane Boivin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale, Vassilios Kaltsatos, Patrick Forget, Eliane Boivin filed Critical Ceva Sante Animale
Priority to JP2007548863A priority Critical patent/JP2008526719A/ja
Priority to US11/794,542 priority patent/US20090281070A1/en
Priority to CA002594273A priority patent/CA2594273A1/fr
Priority to EP05850552A priority patent/EP1830811A2/fr
Publication of WO2006072685A2 publication Critical patent/WO2006072685A2/fr
Publication of WO2006072685A3 publication Critical patent/WO2006072685A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention est un procédé de préparation d'une composition pharmaceutique solide à libération prolongée et contrôlée par traitement aux hautes pressions d'une composition solide comprenant au moins un principe actif et au moins un polymère. L'invention concerne également les compositions pharmaceutiques solides ainsi obtenues.
PCT/FR2005/003203 2004-12-30 2005-12-20 Procede de preparation d'une composition pharmaceutique solide a liberation prolongee et controlee par traitement sous hautes pressions WO2006072685A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2007548863A JP2008526719A (ja) 2004-12-30 2005-12-20 高圧処理により持続性放出制御型の固形医薬組成物を製造する方法
US11/794,542 US20090281070A1 (en) 2004-12-30 2005-12-20 Method for Preparing a Solid Pharmaceutical Composition with Sustained and Controlled Release by High Pressure Treatment
CA002594273A CA2594273A1 (fr) 2004-12-30 2005-12-20 Procede de preparation d'une composition pharmaceutique solide a liberation prolongee et controlee par traitement sous hautes pressions
EP05850552A EP1830811A2 (fr) 2004-12-30 2005-12-20 Procede de preparation d'une composition pharmaceutique solide a liberation prolongee et controlee par traitement sous hautes pressions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0414099 2004-12-30
FR0414099A FR2880273B1 (fr) 2004-12-30 2004-12-30 Procede de separation d'une composition pharmaceutique solide a liberation prolongee et controlee sous hautes pressions

Publications (2)

Publication Number Publication Date
WO2006072685A2 WO2006072685A2 (fr) 2006-07-13
WO2006072685A3 true WO2006072685A3 (fr) 2006-08-31

Family

ID=34954133

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2005/003203 WO2006072685A2 (fr) 2004-12-30 2005-12-20 Procede de preparation d'une composition pharmaceutique solide a liberation prolongee et controlee par traitement sous hautes pressions

Country Status (6)

Country Link
US (1) US20090281070A1 (fr)
EP (1) EP1830811A2 (fr)
JP (1) JP2008526719A (fr)
CA (1) CA2594273A1 (fr)
FR (1) FR2880273B1 (fr)
WO (1) WO2006072685A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2163240A1 (fr) * 2008-09-12 2010-03-17 Universita' Degli Studi Di Genova Méthode pour la production des matrices compactes bioadhésives
WO2010123563A2 (fr) * 2009-04-23 2010-10-28 Sustained Nano Systems Llc Dispositif d'administration à libération contrôlée
JP2011026212A (ja) * 2009-07-21 2011-02-10 Sawai Pharmaceutical Co Ltd 保存安定性に優れ、良好な打錠性を有するフルボキサミンマレイン酸塩錠剤
AU2018300071A1 (en) 2017-07-11 2020-02-13 Sustained Nano Systems Llc Radiation sterilization of hypercompressed polymer dosage forms
AU2018300080A1 (en) 2017-07-11 2020-02-13 Sustained Nano Systems Llc Hypercompressed pharmaceutical formulations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US20030228367A1 (en) * 2000-03-13 2003-12-11 Brown University Research Foundation Liquid crystalline polymers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2872429B1 (fr) * 2004-07-02 2008-05-09 Ellipse Pharmaceuticals Sa Procede de fabrication d'une forme pharmaceutique a liberation controlee contenant au moins un principe actif

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591496A (en) * 1984-01-16 1986-05-27 Massachusetts Institute Of Technology Process for making systems for the controlled release of macromolecules
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US20030228367A1 (en) * 2000-03-13 2003-12-11 Brown University Research Foundation Liquid crystalline polymers

Also Published As

Publication number Publication date
JP2008526719A (ja) 2008-07-24
FR2880273B1 (fr) 2007-03-30
WO2006072685A2 (fr) 2006-07-13
CA2594273A1 (fr) 2006-07-13
FR2880273A1 (fr) 2006-07-07
US20090281070A1 (en) 2009-11-12
EP1830811A2 (fr) 2007-09-12

Similar Documents

Publication Publication Date Title
EP1740156B8 (fr) Procede de production d'une forme galenique solide protegee contre un usage detourne
WO2007146965A3 (fr) Composés destinés au traitement d'une maladie périodontale
WO2007019439A3 (fr) Compositions de copolymere sequence et utilisations de ces dernieres
WO2007010034A3 (fr) Copolymere ampholyte, sa production et son utilisation
WO2007071915A3 (fr) Produit pharmaceutique
WO2008019357A3 (fr) Composés d'indole
IL189008A (en) History of 1-Naphthalenyl-3-azabicyclo [0.1.3] hexane
EP2308870A3 (fr) Dérivés de 2-oxo-1-pyrrolidine, leurs procédés de préparation et leurs utilisations
EP1129693A3 (fr) Composition pour la prévention des odeurs corporelle et son usage
WO2007124090A3 (fr) Formulations de molécule peptide(s)-anticorps thérapeutique lyophilisée
WO2007052289A3 (fr) Nouvelle composition de comprime dispersible
WO2008037716A3 (fr) Compositions pharmaceutiques
WO2007014930A3 (fr) Copolymeres de polyammonium-polysiloxane
EP1941798A3 (fr) Compositions nematicides
WO2006124713A3 (fr) 4-biarylyl-1-phenylazetidin-2-ones
WO2007147010A3 (fr) Appareils médicaux implantables et méthodes pour les fabriquer
WO2006103657A3 (fr) Composition solide de distribution intra-buccale d'insuline
WO2007084857A3 (fr) Procédés et compositions de traitement de troubles prolifératifs cellulaires
WO2008066630A3 (fr) Procédés de reprogrammation de cellules somatiques adultes, et leurs utilisations
WO2008128775A3 (fr) Composition pharmaceutique stabilisée contenant de la prégabaline
WO2006034035A3 (fr) Traitement de l'ischemie
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
WO2007029087A3 (fr) Preparations multi-unites a liberation controlee
WO2011077239A3 (fr) Compositions pharmaceutiques d'ilopéridone à libération lente
WO2006091836A8 (fr) Preparations de tartrate de ladostigil

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005850552

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007548863

Country of ref document: JP

Ref document number: 2594273

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 11794542

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2005850552

Country of ref document: EP